Abstract

Scarring remains a large market with as yet no prescription medication to reduce or prevent scarring. Studies have indicated that early human fetuses can heal cutaneous wounds with perfect regeneration and a number of theories have been proposed for this regenerative phenotype. These theories and variations between fetal and adult wound healing have been studied and a number have been patented as future potential therapeutics to reduce or prevent scarring.

Keywords: Fetal wound healing, inflammation, regeneration, scar, TGF-β, wound healing